Immunotherapy for the Treatment of Alzheimer’s Disease

Pages: 331 - 359
Published: Jan 1, 2017
Abstract
Both active and passive anti-β-amyloid (Aβ) immunotherapies have been reported to clear brain Aβ deposits in transgenic mouse models of Alzheimer's disease (AD). These studies have also indicated that anti-Aβ immunotherapy not only reduces cerebral Aβ burden in the brain but also causes a reduction in cognitive decline. However, results in transgenic mice do not translate well in humans. AN1792 is a vaccine that is composed of preaggregated...
Paper Details
Title
Immunotherapy for the Treatment of Alzheimer’s Disease
Published Date
Jan 1, 2017
Journal
Pages
331 - 359
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.